Abstract
In this study, we demonstrated the potential use of nucleic acid ligand (aptamers) conjugated gold nanoparticles (AuNPs) for cancer cell detection. Through specific binding of the aptamers toward platelet-derived growth factor (PDGF), MDA-MB-231 and Hs578T cells (cancer cells) that over-express PDGF, interact with Apt-AuNPs to a greater extent than do H184B5F5/M10 cells (normal cells). These results were confirmed through inductively coupled plasma mass spectrometry measurements of the gold ion concentrations within these cells. Aggregation of the Apt-AuNPs in the cytoplasm of the cancer cells led to the generation of an intense scattered light upon photo-illumination; this phenomenon allows the differentiation of cancer cells from normal cells using a dark field optical microscope. The presence of Apt-AuNPs suppressed the proliferation of MDA-MB-231 cancer cells, but not H184B5F5/M10 cells.
Similar content being viewed by others
References
Alivisatos AP, Gu W, Larabell C (2005) Quantum dots as cellular probes. Annu Rev Biomed Eng 7:55–76
Bhattacharya R et al (2004) Gold nanoparticles inhibit VEGF165-induced proliferation of HUVEC cells. Nano Lett 4(12):2479–2481
Bronzert DA et al (1987) Synthesis and secretion of platelet-derived growth-factor by human-breast cancer cell-lines. Proc Natl Acad Sci USA 84(16):5763–5767
Chan WCW, Nie S (1998) Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 281(5385):2016–2018
Chen J et al (2005) Gold nanocages: bioconjugation and their potential use as optical imaging contrast agents. Nano Lett 5(3):473–477
Coltrera MD, Wang J, Porter PL, Gown AM (1995) Expression of platelet-derived growth-factor B-chain and the platelet-derived growth-factor receptor-beta subunit in human breast-tissue and breast-carcinoma. Cancer Res 55(12):2703–2708
Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD (2005) Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1(3):325–327
de la Fuente JM, Berry CC, Riehle MO, Curtis ASG (2006) Nanoparticle targeting at cells. Langmuir 22(7):3286–3293
El-Sayed IH, Huang X, El-Sayed MA (2005) Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. Nano Lett 5(5):829–834
Farokhzad OC et al (2004) Nanopartide-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res 64(21):7668–7672
Farokhzad OC et al (2006) Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci USA 103(16):6315–6320
Floege J et al (1999) Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor inGlomerulonephritis by aptamers. Am J Pathol 154(1):169–179
Frens G (1973) Controlled nucleation for regulation of particle-size in monodisperse gold suspensions. Nat Phys Sci 241(105):20–22
Fukumori Y, Ichikawa H (2006) Nanoparticles for cancer therapy and diagnosis. Adv Powder Technol 17(1):1–28
Grabar KC, Freeman RG, Hommer MB, Natan MJ (1995) Preparation and characterization of Au colloid monolayers. Anal Chem 67(4):735–743
Green LS et al (1996) Inhibitory DNA ligands to platelet-derived growth factor B-chain. Biochemistry 35(45):14413–14424
Green R, Ellington AD, Szostak JW (1990) In vitro genetic-analysis of the tetrahymena self-splicing intron. Nature 347(6291):406–408
Hamula CLA, Guthrie JW, Zhang H, Li X-F, Le XC (2006) Selection and analytical applications of aptamers. Trac-Trends Anal Chem 25(7):681–691
Heldin C-H, Westermark B (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79(4):1283–1316
Herr JK, Smith JE, Medley CD, Shangguan D, Tan W (2006) Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells. Anal Chem 78(9):2918–2924
Horisberger M (1981) Colloidal gold—a cytochemical marker for light and fluorescent microscopy and for transmission and scanning electron-microscopy. Scan Electron Micros II:9–32
Hu M et al (2006) Gold nanostructures: engineering their plasmonic properties for biomedical applications. Chem Soc Rev 35(11):1084–1094
Huang C-C, Huang Y-F, Cao Z, Tan W, Chang H-T (2005) Aptamer-modified gold nanoparticles for colorimetric determination of platelet-derived growth factors and their receptors. Anal Chem 77(17):5735–5741
Huang X, El-Sayed IH, Qian W, El-Sayed MA (2006) Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 128(6):2115–2120
Jain KK (2005) Nanotechnology-based drug delivery for cancer. Technol Cancer Res Treat 4(4):407–416
Jana NR, Gearheart L, Murphy CJ (2001) Seeding growth for size control of 5–40 nm diameter gold nanoparticles. Langmuir 17(22):6782–6786
Leitzel K et al (1991) Elevated plasma platelet-derived growth-factor-B-chain levels in cancer-patients. Cancer Res 51(16):4149–4154
Liu X, Atwater M, Wang J, Huo Q (2007) Extinction coefficient of gold nanoparticles with different sizes and different capping ligands. Colloids Surf B Biointerfaces 58(1):3–7
Loo C, Lowery A, Halas N, West J, Drezek R (2005) Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett 5(4):709–711
Peres R, Betsholtz C, Westermark B, Heldin C-H (1987) Frequent expression of growth-factors for mesenchymal cells in human mammary-carcinoma cell-lines. Cancer Res 47(13):3425–3429
Pernodet N et al (2006) Adverse effects of citrate/gold nanoparticles on human dermal fibroblasts. Small 2(6):766–773
Pissuwan D, Valenzuela SM, Cortie MB (2006) Therapeutic possibilities of plasmonically heated gold nanoparticles. Trends Biotechnol 24(2):62–67
Proske D, Blank M, Buhmann R, Resch A (2005) Aptamers—basic research, drug development, and clinical applications. Appl Microbiol Biotechnol 69(4):367–374
Sokolov K et al (2003a) Optical systems for in vivo molecular imaging of cancer. Technol Cancer Res Treat 2(6):491–504
Sokolov K et al (2003b) Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res 63(9):1999–2004
Storhoff JJ, Elghanian R, Mucic RC, Mirkin CA, Letsinger RL (1998) One-pot colorimetric differentiation of polynucleotides with single base imperfections using gold nanoparticle probes. J Am Chem Soc 120(9):1959–1964
Thomas M, Klibanov AM (2003) Conjugation to gold nanoparticles enhances polyethylenimine’s transfer of plasmid DNA into mammalian cells. Proc Natl Acad Sci USA 100(16):9138–9143
Tkachenko AG et al (2003) Multifunctional gold nanoparticle-peptide complexes for nuclear targeting. J Am Chem Soc 125(16):4700–4701
Tombelli S, Minunni M, Mascini M (2005) Analytical applications of aptamers. Biosens Bioelectron 20(12):2424–2434
Tsoli M, Kuhn H, Brandau W, Esche H, Schmid G (2005) Cellular uptake and toxicity of AU(55) clusters. Small 1(8–9):841–844
Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment—rna ligands to bacteriophage-T4 DNA-polymerase. Science 249(4968):505–510
Yelin D, Oron D, Thiberge S, Moses E, Silberberg Y (2003) Multiphoton plasmon-resonance microscopy. Opt Express 11(12):1385–1391
Yguerabide J, Yguerabide EE (1998) Light-scattering submicroscopic particles as highly fluorescent analogs and their use as tracer labels in clinical and biological applications: I. Theory Anal Biochem 262(2):137–156
Zhi PX, Qing HZ, Gao QL, Ai BY (2006) Inorganic nanoparticles as carriers for efficient cellular delivery. Chem Eng Sci 61(3):1027–1040
Acknowledgements
This study was supported by the National Science Council (NSC 95-2113-M-002-026-MY3, NSC 96-2627-M-002 -013 and NSC 96-2627-M-002 -014) of Taiwan. We are grateful to Messrs Ching-Yen Lin and Chih-Yuan Tang of the Instrumentation Center, National Taiwan University, for their assistance in conducting the TEM measurements.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huang, YF., Lin, YW., Lin, ZH. et al. Aptamer-modified gold nanoparticles for targeting breast cancer cells through light scattering. J Nanopart Res 11, 775–783 (2009). https://doi.org/10.1007/s11051-008-9424-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11051-008-9424-x